Last updated on February 2018

Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis

Brief description of study

The purpose of this study is to identify whether an Accelerated or Intensified Infliximab induction regimen is superior to Standard induction in Acute Severe Ulcerative Colitis in an open label multi-centre randomised controlled trial.

Clinical Study Identifier: NCT02770040

Find a site near you

Start Over

Austin Health

Melbourne, Australia
  Connect »